LEGN Stock Forecast

Outlook: LEGN is assigned short-term B1 & long-term Ba3 estimated rating.
AUC Score : What is AUC Score?
Short-term Tactic¹ :
Dominant Strategy :
Time series to forecast n: for Weeks²
ML Model Testing : Transfer Learning (ML)
Hypothesis Testing : Multiple Regression
Surveillance : Major exchange and OTC

¹Short-term revised.

²Time series is updated based on short-term trends.

Key Points

Legend Biotech ADS is poised for continued growth, driven by the sustained demand and expanding market for its CAR-T therapies. Predictions include further clinical trial successes and potential regulatory approvals for new indications, which could significantly broaden its revenue streams. A key risk, however, centers on increased competition from established and emerging biopharmaceutical companies developing similar or alternative treatments. Furthermore, the complex and costly manufacturing processes inherent in CAR-T therapy production present ongoing operational challenges and potential for unforeseen delays, impacting profitability and stock performance. The company's reliance on a specific set of therapies also exposes it to the risk of adverse clinical trial outcomes or unexpected safety signals, which could have a severe impact on its valuation.

About LEGN

Legend Biotech is a global biotechnology company focused on developing and commercializing novel cell therapies for patients with life-threatening diseases. The company's primary emphasis is on innovative treatments for various types of cancer, leveraging its proprietary CAR-T (chimeric antigen receptor T-cell) platform. Legend Biotech is dedicated to advancing the field of cell therapy through rigorous research and development, aiming to create therapies that are both effective and accessible to a broader patient population.

The company's core strategy involves a multi-faceted approach to drug discovery and development, including extensive preclinical research, robust clinical trials, and strategic partnerships with leading pharmaceutical entities. Legend Biotech's commitment to scientific excellence and patient-centric innovation positions it as a significant player in the biopharmaceutical landscape, with a pipeline of promising candidates that hold the potential to address significant unmet medical needs.

This exclusive content is only available to premium users.

ML Model Testing

F(Multiple Regression)^6,7= $\begin{array}{cccc}{p}_{\mathrm{a}1}& p_{\mathrm{a}2}& \dots & p_{1n}\\ & ⋮\\ p_{j1}& p_{j2}& \dots & p_{jn}\\ & ⋮\\ p_{k1}& p_{k2}& \dots & p_{kn}\\ & ⋮\\ p_{n1}& p_{n2}& \dots & p_{nn}\end{array}$ X R(Transfer Learning (ML))^3,4,5 X S(n):→ 1 Year $\begin{array}{l}\int e^x\mathrm{rx}\end{array}$

n:Time series to forecast

p:Price signals of LEGN stock

j:Nash equilibria (Neural Network)

k:Dominated move of LEGN stock holders

a:Best response for LEGN target price

 

For further technical information as per how our model work we invite you to visit the article below: 

How do KappaSignal algorithms actually work?

LEGN Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

This exclusive content is only available to premium users.

Rating	Short-Term	Long-Term Senior
Outlook	B1	Ba3
Income Statement	Ba2	Baa2
Balance Sheet	C	Baa2
Leverage Ratios	Ba3	B1
Cash Flow	Baa2	B2
Rates of Return and Profitability	Caa2	C

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

References

1. M. Sobel. The variance of discounted Markov decision processes. Applied Probability, pages 794–802, 1982
2. Wu X, Kumar V, Quinlan JR, Ghosh J, Yang Q, et al. 2008. Top 10 algorithms in data mining. Knowl. Inform. Syst. 14:1–37
3. Cortes C, Vapnik V. 1995. Support-vector networks. Mach. Learn. 20:273–97
4. Byron, R. P. O. Ashenfelter (1995), "Predicting the quality of an unborn grange," Economic Record, 71, 40–53.
5. Zou H, Hastie T. 2005. Regularization and variable selection via the elastic net. J. R. Stat. Soc. B 67:301–20
6. Athey S, Tibshirani J, Wager S. 2016b. Generalized random forests. arXiv:1610.01271 [stat.ME]
7. D. Bertsekas. Nonlinear programming. Athena Scientific, 1999.